ZKSCAN3 and hepatocellular carcinoma: Clinical therapeutic relevance studies have shown that ZKSCAN3 reduces the sensitivity of hepatocellular carcinoma cells to 5-FU chemotherapy by inhibiting their senescence, and its high expression is positively correlated with hepatocellular carcinoma proliferation, invasion, and lung metastatic potential.